Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.02 (+4.71%)
At close: Oct 20, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Other Operating Expenses (2020 - 2025)

Updated

Jasper Therapeutics (JSPR) recorded Other Operating Expenses of -$15.77 million in Q2 2025, compared with -$6.21 million a year earlier.

Analysis

Jasper Therapeutics (JSPR) Other Operating Expenses (2020 - 2025) Analysis & Trends

For FY2024, Jasper Therapeutics reported Other Operating Expenses of -$34.27 million.

  • Across earlier years, Other Operating Expenses came in at -$36.78 million in FY2023, $436,000 in FY2021 (-39.6%) and $722,000 in FY2020.
  • The Q2 2025 figure is the lowest quarterly Other Operating Expenses in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Jasper Therapeutics 14.34 Mn -112.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -15.77 Mn
Mar 31, 2025 -9.76 Mn
Jun 30, 2024 -6.21 Mn
Mar 31, 2024 -6.11 Mn
Dec 31, 2022 8.44 Mn
Sep 30, 2022 475,000.00
Jun 30, 2022 480,000.00
Mar 31, 2022 556,000.00
Dec 31, 2021 99,000.00
Sep 30, 2021 80,000.00
Jun 30, 2021 129,000.00
Mar 31, 2021 128,000.00
Dec 31, 2020 172,000.00
Sep 30, 2020 170,000.00
API Access

Jasper Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=JSPR&period=max&api_key=YOUR_API_KEY